MD20150104A2 - Derivaţi ai benzimidazolonei în calitate de inhibitori ai bromodomeniului - Google Patents
Derivaţi ai benzimidazolonei în calitate de inhibitori ai bromodomeniului Download PDFInfo
- Publication number
- MD20150104A2 MD20150104A2 MDA20150104A MD20150104A MD20150104A2 MD 20150104 A2 MD20150104 A2 MD 20150104A2 MD A20150104 A MDA20150104 A MD A20150104A MD 20150104 A MD20150104 A MD 20150104A MD 20150104 A2 MD20150104 A2 MD 20150104A2
- Authority
- MD
- Moldova
- Prior art keywords
- compounds
- bromodomain inhibitors
- benzimidazolone derivatives
- bromodomain
- inhibitors
- Prior art date
Links
- 102000001805 Bromodomains Human genes 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 108050009021 Bromodomains Proteins 0.000 title 1
- 150000008641 benzimidazolones Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- 102100029895 Bromodomain-containing protein 4 Human genes 0.000 abstract 2
- 101710126815 Bromodomain-containing protein 4 Proteins 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 108091005575 Bromodomain-containing proteins Proteins 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Invenţia se referă la compuşi chimici care pot acţiona ca inhibitori sau care altminteri pot modula activitatea unei proteine conţinând un domeniu bromic, inclusiv a proteinei conţinând domeniul bromic 4 (BRD4), şi la compoziţii şi formulări ce conţin astfel de compuşi, precum şi la metode de utilizare şi obţinere a astfel de compuşi. Compuşii includ compuşi cu formula (I)(I),în care R1a, R1b, R2a, R2b, R3 şi X sunt descrise în prezenta cerere.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361805995P | 2013-03-28 | 2013-03-28 | |
| US201361860230P | 2013-07-30 | 2013-07-30 | |
| PCT/US2014/032031 WO2014160873A1 (en) | 2013-03-28 | 2014-03-27 | Benzimidazolone derivatives as bromodomain inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| MD20150104A2 true MD20150104A2 (ro) | 2016-02-29 |
| MD4531B1 MD4531B1 (ro) | 2017-11-30 |
| MD4531C1 MD4531C1 (ro) | 2018-06-30 |
Family
ID=50897885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20150104A MD4531C1 (ro) | 2013-03-28 | 2014-03-27 | Derivaţi ai benzimidazolonei în calitate de inhibitori ai bromodomeniului |
Country Status (35)
| Country | Link |
|---|---|
| US (2) | US20160031868A1 (ro) |
| EP (1) | EP2978759B1 (ro) |
| JP (1) | JP6339175B2 (ro) |
| KR (1) | KR101847698B1 (ro) |
| CN (1) | CN105102453B (ro) |
| AP (1) | AP2015008741A0 (ro) |
| AU (1) | AU2014241152B2 (ro) |
| BR (1) | BR112015024078A2 (ro) |
| CA (1) | CA2907502C (ro) |
| CL (1) | CL2015002871A1 (ro) |
| CR (1) | CR20150515A (ro) |
| CY (1) | CY1119165T1 (ro) |
| DK (1) | DK2978759T3 (ro) |
| EA (1) | EA029497B1 (ro) |
| ES (1) | ES2626397T3 (ro) |
| HR (1) | HRP20170750T1 (ro) |
| HU (1) | HUE034772T2 (ro) |
| IL (1) | IL241186A0 (ro) |
| LT (1) | LT2978759T (ro) |
| MD (1) | MD4531C1 (ro) |
| MX (1) | MX2015013798A (ro) |
| MY (1) | MY176634A (ro) |
| NZ (1) | NZ711586A (ro) |
| PE (1) | PE20151982A1 (ro) |
| PH (1) | PH12015502246A1 (ro) |
| PL (1) | PL2978759T3 (ro) |
| PT (1) | PT2978759T (ro) |
| RS (1) | RS56050B1 (ro) |
| SG (1) | SG11201507926RA (ro) |
| SI (1) | SI2978759T1 (ro) |
| SM (1) | SMT201700249T1 (ro) |
| TW (1) | TWI530499B (ro) |
| UY (1) | UY35516A (ro) |
| WO (1) | WO2014160873A1 (ro) |
| ZA (1) | ZA201506356B (ro) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117821344A (zh) * | 2024-03-06 | 2024-04-05 | 江苏古道农业科技有限公司 | 一种草甘膦降解菌及其应用 |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007345526B2 (en) | 2007-02-01 | 2013-02-28 | Resverlogix Corp. | Compounds for the prevention and treatment of cardiovascular diseases |
| AU2010224523B2 (en) | 2009-03-18 | 2014-05-08 | Resverlogix Corp. | Novel anti-inflammatory agents |
| LT2773354T (lt) | 2011-11-01 | 2019-08-12 | Resverlogix Corp. | Geriamosios greitai atsipalaiduojančios pakeistų chinozolinų vaisto formos |
| WO2014080291A2 (en) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Biaryl derivatives as bromodomain inhibitors |
| US9073878B2 (en) | 2012-11-21 | 2015-07-07 | Zenith Epigenetics Corp. | Cyclic amines as bromodomain inhibitors |
| US9271978B2 (en) | 2012-12-21 | 2016-03-01 | Zenith Epigenetics Corp. | Heterocyclic compounds as bromodomain inhibitors |
| MX366703B (es) | 2013-03-15 | 2019-07-22 | Incyte Holdings Corp | Heterociclos tricíclicos como inhibidores de la proteína bet. |
| US9662311B2 (en) * | 2013-06-21 | 2017-05-30 | Zenith Epigenetics Ltd. | Substituted bicyclic compounds as bromodomain inhibitors |
| BR112015031073B1 (pt) * | 2013-06-21 | 2022-11-29 | Zenith Epigenetics Ltd | Compostos inibidores bicíclicos de bromodomínio e composição farmacêutica contendo os referidos compostos |
| US9290514B2 (en) | 2013-07-08 | 2016-03-22 | Incyte Holdings Corporation | Tricyclic heterocycles as BET protein inhibitors |
| CN105593224B (zh) | 2013-07-31 | 2021-05-25 | 恒元生物医药科技(苏州)有限公司 | 作为溴结构域抑制剂的新型喹唑啉酮类化合物 |
| WO2015081189A1 (en) | 2013-11-26 | 2015-06-04 | Incyte Corporation | Bicyclic heterocycles as bet protein inhibitors |
| WO2015081203A1 (en) | 2013-11-26 | 2015-06-04 | Incyte Corporation | Bicyclic heterocycles as bet protein inhibitors |
| US9309246B2 (en) | 2013-12-19 | 2016-04-12 | Incyte Corporation | Tricyclic heterocycles as BET protein inhibitors |
| LT3674302T (lt) | 2014-04-23 | 2023-06-12 | Incyte Holdings Corporation | 1h-pirolo[2,3-c]piridin-7(6h)-onai ir pirazolo[3,4-c]piridin-7(6h)-onai kaip bet baltymų inhibitoriai |
| US9527864B2 (en) | 2014-09-15 | 2016-12-27 | Incyte Corporation | Tricyclic heterocycles as BET protein inhibitors |
| JP6930913B2 (ja) | 2014-10-14 | 2021-09-01 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアＴｈｅ Ｒｅｇｅｎｔｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃａｌｉｆｏｒｎｉａ | 炎症を阻害するためのｃｄｋ９及びｂｒｄ４阻害剤の使用法 |
| US10179125B2 (en) | 2014-12-01 | 2019-01-15 | Zenith Epigenetics Ltd. | Substituted pyridines as bromodomain inhibitors |
| US10710992B2 (en) | 2014-12-01 | 2020-07-14 | Zenith Epigenetics Ltd. | Substituted pyridinones as bromodomain inhibitors |
| WO2016092375A1 (en) | 2014-12-11 | 2016-06-16 | Zenith Epigenetics Corp. | Substituted heterocycles as bromodomain inhibitors |
| US10231953B2 (en) | 2014-12-17 | 2019-03-19 | Zenith Epigenetics Ltd. | Inhibitors of bromodomains |
| CN107530356A (zh) | 2015-03-13 | 2018-01-02 | 雷斯韦洛吉克斯公司 | 用于治疗补体相关疾病之组合物及治疗方法 |
| GB201504689D0 (en) | 2015-03-19 | 2015-05-06 | Glaxosmithkline Ip Dev Ltd | Chemical compounds |
| GB201504694D0 (en) | 2015-03-19 | 2015-05-06 | Glaxosmithkline Ip Dev Ltd | Covalent conjugates |
| WO2016203335A1 (en) | 2015-06-18 | 2016-12-22 | Pfizer Inc. | Novel pyrido[2,3-b]pyrazinones as bet-family bromodomain inhibitors |
| US20170121347A1 (en) | 2015-10-29 | 2017-05-04 | Incyte Corporation | Amorphous solid form of a bet protein inhibitor |
| WO2017114843A1 (en) | 2015-12-29 | 2017-07-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Xanthine derivative inhibitors of bet proteins |
| PT3472157T (pt) | 2016-06-20 | 2023-05-30 | Incyte Corp | Formas sólidas cristalinas de um inibidor bet |
| WO2018097976A1 (en) * | 2016-11-22 | 2018-05-31 | Gilead Sciences, Inc. | Synthesis of a compound that modulates the activity of bromodomain-containing proteins |
| JP7254075B2 (ja) | 2017-11-06 | 2023-04-07 | サントル ナショナル ドゥ ラ ルシェルシュ シアンティフィック | キサンチン誘導体及びｂｅｔタンパク質のブロモドメインの阻害剤としてのその使用 |
| US11466034B2 (en) * | 2017-12-20 | 2022-10-11 | Betta Pharmaceuticals Co., Ltd. | Compound functioning as bromodomain protein inhibitor, and composition |
| US12358925B2 (en) * | 2019-02-02 | 2025-07-15 | Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd | Targeted ubiquitination degradation BRD4 protein compound, preparation method therefor and application thereof |
| CN109912584B (zh) * | 2019-03-22 | 2021-08-13 | 中国药科大学 | 一种具有抗肿瘤活性的brd4蛋白抑制剂及其制备方法和应用 |
| CA3152923A1 (en) | 2019-09-30 | 2021-04-08 | Keisuke Yamamoto | Bet degrader |
| WO2021237111A1 (en) * | 2020-05-21 | 2021-11-25 | Stemsynergy Therapeutics, Inc. | Notch inhibitors and uses thereof |
| US11833155B2 (en) | 2020-06-03 | 2023-12-05 | Incyte Corporation | Combination therapy for treatment of myeloproliferative neoplasms |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US4326525A (en) | 1980-10-14 | 1982-04-27 | Alza Corporation | Osmotic device that improves delivery properties of agent in situ |
| US5364620A (en) * | 1983-12-22 | 1994-11-15 | Elan Corporation, Plc | Controlled absorption diltiazem formulation for once daily administration |
| US5023252A (en) * | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US4992445A (en) | 1987-06-12 | 1991-02-12 | American Cyanamid Co. | Transdermal delivery of pharmaceuticals |
| US5001139A (en) * | 1987-06-12 | 1991-03-19 | American Cyanamid Company | Enchancers for the transdermal flux of nivadipine |
| US4902514A (en) * | 1988-07-21 | 1990-02-20 | Alza Corporation | Dosage form for administering nilvadipine for treating cardiovascular symptoms |
| US6162804A (en) | 1997-09-26 | 2000-12-19 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| EP1620413A2 (en) | 2003-04-30 | 2006-02-01 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| GB0420719D0 (en) | 2004-09-17 | 2004-10-20 | Addex Pharmaceuticals Sa | Novel allosteric modulators |
| EA201000201A1 (ru) | 2007-08-10 | 2010-12-30 | ГЛАКСОСМИТКЛАЙН ЭлЭлСи | Азотсодержащие бициклические химические вещества для лечения вирусных инфекций |
| US20100204265A1 (en) | 2009-02-09 | 2010-08-12 | Genelabs Technologies, Inc. | Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections |
| GB0919423D0 (en) | 2009-11-05 | 2009-12-23 | Glaxosmithkline Llc | Novel compounds |
| ES2786298T3 (es) | 2011-03-03 | 2020-10-09 | Zalicus Pharmaceuticals Ltd | Inhibidores de benzimidazol del canal de sodio |
| GB201114103D0 (en) | 2011-08-17 | 2011-09-28 | Glaxosmithkline Llc | Novel compounds |
| BR112015031073B1 (pt) * | 2013-06-21 | 2022-11-29 | Zenith Epigenetics Ltd | Compostos inibidores bicíclicos de bromodomínio e composição farmacêutica contendo os referidos compostos |
-
2014
- 2014-03-26 TW TW103111238A patent/TWI530499B/zh not_active IP Right Cessation
- 2014-03-27 EP EP14729114.0A patent/EP2978759B1/en active Active
- 2014-03-27 SG SG11201507926RA patent/SG11201507926RA/en unknown
- 2014-03-27 AP AP2015008741A patent/AP2015008741A0/xx unknown
- 2014-03-27 DK DK14729114.0T patent/DK2978759T3/da active
- 2014-03-27 BR BR112015024078A patent/BR112015024078A2/pt not_active Application Discontinuation
- 2014-03-27 MD MDA20150104A patent/MD4531C1/ro not_active IP Right Cessation
- 2014-03-27 WO PCT/US2014/032031 patent/WO2014160873A1/en active Application Filing
- 2014-03-27 HU HUE14729114A patent/HUE034772T2/en unknown
- 2014-03-27 HR HRP20170750TT patent/HRP20170750T1/hr unknown
- 2014-03-27 US US14/774,019 patent/US20160031868A1/en not_active Abandoned
- 2014-03-27 SM SM20170249T patent/SMT201700249T1/it unknown
- 2014-03-27 EA EA201591455A patent/EA029497B1/ru not_active IP Right Cessation
- 2014-03-27 NZ NZ711586A patent/NZ711586A/en not_active IP Right Cessation
- 2014-03-27 CN CN201480018645.6A patent/CN105102453B/zh active Active
- 2014-03-27 PE PE2015002057A patent/PE20151982A1/es not_active Application Discontinuation
- 2014-03-27 KR KR1020157030708A patent/KR101847698B1/ko active Active
- 2014-03-27 PT PT147291140T patent/PT2978759T/pt unknown
- 2014-03-27 MX MX2015013798A patent/MX2015013798A/es unknown
- 2014-03-27 ES ES14729114.0T patent/ES2626397T3/es active Active
- 2014-03-27 SI SI201430191A patent/SI2978759T1/sl unknown
- 2014-03-27 RS RS20170569A patent/RS56050B1/sr unknown
- 2014-03-27 US US14/227,736 patent/US9255089B2/en active Active
- 2014-03-27 JP JP2016505567A patent/JP6339175B2/ja not_active Expired - Fee Related
- 2014-03-27 MY MYPI2015002440A patent/MY176634A/en unknown
- 2014-03-27 CA CA2907502A patent/CA2907502C/en not_active Expired - Fee Related
- 2014-03-27 PL PL14729114T patent/PL2978759T3/pl unknown
- 2014-03-27 LT LTEP14729114.0T patent/LT2978759T/lt unknown
- 2014-03-27 AU AU2014241152A patent/AU2014241152B2/en not_active Ceased
- 2014-03-28 UY UY0001035516A patent/UY35516A/es not_active Application Discontinuation
-
2015
- 2015-08-31 ZA ZA2015/06356A patent/ZA201506356B/en unknown
- 2015-09-06 IL IL241186A patent/IL241186A0/en unknown
- 2015-09-24 PH PH12015502246A patent/PH12015502246A1/en unknown
- 2015-09-25 CL CL2015002871A patent/CL2015002871A1/es unknown
- 2015-10-02 CR CR20150515A patent/CR20150515A/es unknown
-
2017
- 2017-06-13 CY CY20171100624T patent/CY1119165T1/el unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117821344A (zh) * | 2024-03-06 | 2024-04-05 | 江苏古道农业科技有限公司 | 一种草甘膦降解菌及其应用 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MD20150104A2 (ro) | Derivaţi ai benzimidazolonei în calitate de inhibitori ai bromodomeniului | |
| PH12015502534A1 (en) | Benzimidazole derivatives as bromodomain inhibitors | |
| MA32508B1 (fr) | Composes organiques | |
| PH12015501868A1 (en) | Inhibitors of histone demethylases | |
| MX2012000709A (es) | Inhibidores de pirrolopiridina de cinasas. | |
| UA116467C2 (uk) | Модулятори p2x7 | |
| MY162604A (en) | Heterocyclic compounds and uses thereof | |
| PH12012500674A1 (en) | Heterocyclic compounds useful as pdk1 inhibitors | |
| JO3007B1 (ar) | مركبات و تركيبات كمثبطات كيناز بروتين | |
| CR20160171A (es) | NUEVO OCTAHIDRO-CICLOBUTA[1,2-c; 3,4-c] DIPIRROL-2-ILO | |
| MX2016008110A (es) | Derivados de pirazol como inhibidores de la cinasa de cremallera de leucina dual (dlk) y usos de los mismos. | |
| CR20140135A (es) | Nuevos derivados de aril-quinolina | |
| UY34491A (es) | La composición herbicida que contiene ácido de 4-amino-3-cloro-6- (4-cloro-2-flúor-3-metoxifenil) pyridina-2-carboxílico o los derivados de los mismos y fluroxipir o los derivados de los mismos | |
| MX2015016332A (es) | Inhibidores de alk biciclicos fusionados. | |
| MX368635B (es) | Compuestos tricíclicos de piperidina. | |
| TW200738244A (en) | 20-Alkyl, gemini vitamin D3 compounds and methods of use thereof | |
| UA110131C2 (ru) | ПРОИЗВОДНЫЕ ТИЕНО[2,3-d]ПИРИМИДИНА И ИХ ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ АРИТМИИ | |
| CR20150159A (es) | Derivados oxazolidinona 3,4-disustituidos y su uso como inhibidores de potasio calcio activado | |
| UA111315C2 (uk) | Похідні бензімідазолону як інгібітори бромодомену | |
| MX2013002446A (es) | Derivados de tetrahidropirrolopirazina sustituidos. | |
| TH167410A (th) | อนุพันธ์เบนซิมิดาโซโลนที่เป็นสารยับยั้งโบรโมโดเมน(Benzimidazolone Derivatives as Bromodomain Inhibitors) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG4A | Patent for invention issued | ||
| KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
| MM4A | Patent for invention definitely lapsed due to non-payment of fees |